The elevated expression of astrocytic markers seen in AD, HD and ALS mice is reduced with the genetic and pharmacological blockade of mGlu5 (Hamilton et al., 2016; Abd-Elrahman et al., 2017; Bonifacino et al., 2017; Abd-Elrahman KS. The gene discussed is GRM5; the disease is Huntington disease.